Skip to main content
Log in

Drug use in an intensive care unit and its relation to survival

  • Original Articles
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Summary

Admissions during the first 6 months of 1978, 427 in all, have been reviewed in relation to their pharmacological treatment and mortality rates. They have been divided into five groups according to their diagnoses, and for mortality evaluation. Tagge's prognostic classification was applied. Length of stay, number of drugs used in each patient, and cost of pharmacological therapy, do not have a significant relation to survival.

Conclusions stress the great importance of determining uniform admission criteria to evaluate the degree of effort in money, personnel and hospital support to be spent on these kind of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aranda JV, Cohen S, Neims AM (1976) Drug utilization in a newborn intensive care unit. J Ped 89:315

    Google Scholar 

  2. Buchanan N, Cane RD (1978) Drug utilization in a general intensive care unit. Intens Care Med 4:75

    Google Scholar 

  3. Cimetidine (Tagamet): Update on Adverse Effects (1978) The Med Letter 20:77

  4. Civetta JM (1973) The inverse relationship between cost and survival. J Surg Res 14:441

    Google Scholar 

  5. Cullen J (1977) Results and costs of intensive care. Anesthesiology 47:203

    Google Scholar 

  6. Dixon RE (1979) Infecciones hospitalarias, un problema continuo. JANO 363:73

    Google Scholar 

  7. Gimenez Caballero ME, Garcia Romero MJ (1978) Estudio de las interacciones medicamentosas en los Servicios de Cuidados Médicos Intensivos y de Medicina Interna. Mundo Farmacéutico 4:59

    Google Scholar 

  8. Grenvik A, Babcock R, Loughead M, Powner RD, Snyder JV (1977) Different levels of therapeutic efforts in critical care. Personal report to the II World Congress on Intensive Care. Paris, 19–23 Sept. 1977, Abstract 423. Intens Care Med 3:213

    Google Scholar 

  9. Griner PF (1973) Medical intensive care in the teaching hospital: cost versus benefits. Ann Intern Med 78:581

    Google Scholar 

  10. Ibañez Juve J, Fiol Sala M, Abizanda Campos R (1977) Complicaciones cútaneas isquémicas de la dopamina. Medicina Clínca 68:190

    Google Scholar 

  11. Le Gall JR (1978) Considérations économiques et pronostiques en réanimation Revue du Practicien 28:67

    Google Scholar 

  12. Maudes Rodriguez A, Schoendorff Marin G (1978) Valoracion del enfermo crítico. Med Intensiva 2:1

    Google Scholar 

  13. Snyder J, Jatrewski M, Powner D, Grenvik A, Smith J (1977) Problems on brain death determination. Personal communication to the II World Congress on Intensive Care. Paris, 19–23 Sept. 1977. Abstract 237. Intens Care Med 3:166

    Google Scholar 

  14. Snyder JV, Porell M, Grenvik A, Stickler D, Civetta J, Augenstein J (1977) Prognosis equivalence of illness, and cost benefit in intensive care. Personal communication to the II World Congress on Intensive Care Paris, 19–23 Sept. 1977, Abstract 427. Intens Care Med 3:214

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abizanda Campos, R., Valle Herraez, F.X., Jorda Marcos, R. et al. Drug use in an intensive care unit and its relation to survival. Intensive Care Med 6, 163–168 (1980). https://doi.org/10.1007/BF01757298

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01757298

Key words

Navigation